These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6238499)

  • 1. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
    Kauppila A
    Acta Obstet Gynecol Scand; 1984; 63(5):441-50. PubMed ID: 6238499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
    Dryzhak VI
    Vopr Onkol; 1989; 35(7):771-8. PubMed ID: 2528239
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
    Carlson JA; Allegra JC; Day TG; Wittliff JL
    Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of progestins in the treatment of breast cancer.
    Blumenschein GR
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):7-10. PubMed ID: 6230722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
    Grenman SE; Roberts JA; England BG; Grönroos M; Carey TE
    Gynecol Oncol; 1988 Jun; 30(2):239-50. PubMed ID: 2967231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental combined hormone therapy on human breast carcinomas serially transplanted into nude mice.
    Fukutomi T; Kubota T; Ikeda T; Isobe Y; Kikuyama S; Shimada A; Nakamura A; Nishiumi T; Enomoto K; Ishibiki K
    Jpn J Cancer Res; 1986 Jan; 77(1):92-7. PubMed ID: 2937762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma.
    Riippa P; Kauppila A; Sundström H; Vihko R
    Anticancer Res; 1984; 4(3):109-12. PubMed ID: 6235770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced breast cancer with progestins.
    Løber J; Rose C; Salimtschik M; Mouridsen HT
    Acta Obstet Gynecol Scand Suppl; 1981; 101():39-46. PubMed ID: 7030000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 beta-hydroxysteroid dehydrogenase in human endometrium.
    Neumannová M; Kauppila A; Kivinen S; Vihko R
    Obstet Gynecol; 1985 Nov; 66(5):695-700. PubMed ID: 2997680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen therapy of metastatic breast cancer.
    Manni A
    J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestins in breast cancer treatment. A review.
    Lundgren S
    Acta Oncol; 1992; 31(7):709-22. PubMed ID: 1476750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose progestin therapy for metastatic breast cancer.
    Muss HB; Cruz JM
    Ann Oncol; 1992 Aug; 3 Suppl 3():15-20. PubMed ID: 1390312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term estrogen replacement therapy. II. Neoplasia.
    Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of high-dose progestins in breast cancer.
    Abrams JS; Parnes H; Aisner J
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):68-72. PubMed ID: 2148027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
    Park JY; Lee SH; Seong SJ; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
    Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-steroid hormones for uterine cancer].
    Komiyama S; Nishio E; Yasue A; Hasegawa K; Udagawa Y
    Nihon Rinsho; 2008 Jan; 66(1):174-81. PubMed ID: 18186261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.